LONG-TERM SAFETY AND EFFICACY CLINICAL-TRIAL WITH RECOMBINANT FACTOR-VIII

被引：0

|

作者：

WHITE, G

GOMPERTS, E

LIUMARUYA, S

机构：

[1] UNIV N CAROLINA,RECOMBINATE COLLABORAT STUDY GRP,CHAPEL HILL,NC 27514

[2] BAXTER HULAND DIV,GLENDALE,CA

来源：

THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：705 / 705

页数：1

相关论文

共 50 条

[21] DESIGN OF CLINICAL-STUDIES WITH RECOMBINANT FACTOR-VIII
PENNINGTON, JE
SCHWARTZ, RS
SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 27 - 28
[22] A SUMMARY OF THE WORLDWIDE CLINICAL INVESTIGATIONS OF RECOMBINANT FACTOR-VIII
SCHWARTZ, RS
ROUSELL, RH
SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 53 - 54
[23] CLINICAL DEVELOPMENT OF RECOMBINANT FACTOR-VIII (RFVIII, KOGENATE)
HURST, D
HAEMOPHILIA, 1995, 1 : 26 - 28
[24] DETECTION AND QUANTITATION OF AGGREGATES OF FACTOR-VIII IN RECOMBINANT HUMAN FACTOR-VIII
CHO, Y
GARANCHON, L
KASHI, R
WONG, C
BESMAN, MJ
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1088 - 1088
[25] RECOMBINANT FACTOR-VIII CONCENTRATE
WALKER, I
POON, MC
LANCET, 1992, 339 (8784): : 61 - 62
[26] RECOMBINANT FACTOR-VIII IN HEMOPHILIA
COHEN, A
BUTLER, R
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (21): : 1515 - 1516
[27] THE PHARMACOKINETICS OF RECOMBINANT FACTOR-VIII
HARRISON, JFM
BLOOM, AL
ABILDGAARD, CF
SEMINARS IN HEMATOLOGY, 1991, 28 (02) : 29 - 35
[28] VIRUS SAFETY CONSIDERATIONS FOR RECOMBINANT FACTOR-VIII (RFVIII, KOGENATE)
ARNOLD, D
HAEMOPHILIA, 1995, 1 : 22 - 23
[29] EFFICACY OF CLOZAPINE VS HALOPERIDOL IN A LONG-TERM CLINICAL-TRIAL - PRELIMINARY-RESULTS
AMES, D
WIRSHING, WC
KANE, J
SCHOOLER, N
MARDER, SR
BAKER, R
SAFFERMAN, A
GANGULI, R
UMBRICHT, D
BORENSTEIN, M
BIOLOGICAL PSYCHIATRY, 1995, 37 (09) : 661 - 661
[30] INHIBITOR QUESTIONS - PLASMA-DERIVED FACTOR-VIII AND RECOMBINANT FACTOR-VIII
BRAY, G
ANNALS OF HEMATOLOGY, 1994, 68 : S29 - S34

← 1 2 3 4 5 →